Covidien is now Medtronic Minimally Invasive Therapies


Professional Affairs

We make innovation possible by partnerships dedicated to better patient care.

Through conscientious collaboration, Covidien works with healthcare leaders, professional societies and global organizations.

In the changing healthcare environment, this active dialogue with our partner organizations is essential to ensure that emerging issues are identified and addressed in a timely manner.  By cultivating strong relationships, developing trust and sharing information, we are able to bring to market healthcare solutions to a growing number of patients worldwide.



Covidien Funds Educational Grant to Support Brazilian Stroke Network

New Educational and Training Programs Aim to Improve Stroke Care throughout Brazil

DUBLIN--(BUSINESS WIRE)--Jun. 6, 2012-- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it will support the Brazilian Stroke Network (BSN), a non-governmental organization, through an unrestricted educational grant designed to assist the BSN in its efforts to increase education and awareness about stroke treatment and prevention in Brazil.

According to the BSN, nearly 400,000 strokes occur each year in Brazil, 100,000 of which are fatal – making acute ischemic stroke the leading cause of death in the country.

“Until now, we tried to control hypertension, diabetes and smoking, which had no impact in stroke incidence or stroke mortality,” said Sheila Cristina Ouriques Martins, MD, PhD and President of the BSN. “By educating an underserved population about the prevention and treatment of stroke, we can further our mission to make our community much healthier. Covidien’s funding of this educational grant will bring a valuable educational resource to our medical community, which is committed to reducing stroke in Brazil.”

Dr. Martins and her BSN team, together with Brazilian Stroke Society and Brazilian Academy of Neurology, were recently selected by the World Stroke Organization to receive the Gold Prize award for World Stroke Day 2011. They were recognized for their efforts to mobilize local communities through education and the media.

With Covidien’s unrestricted grant, a new educational course -- Stroke Prevention and Treatment in Brazil – Pre-hospital, Hospital Care and Basic Health Care -- will be offered to designated stroke centers, emergency medical services and primary care professionals throughout Brazil. The course combines e-learning with a hands-on, local effort in which neurologists countrywide train others to develop a best-in-class stroke treatment network across Brazil, facilitating optimal patient access to needed treatments. The Brazilian Stroke Society, Brazilian Neurology Society, Brazilian Medical Association and the BSN are collaborating on the course to help the Ministry of Health implement Brazil’s new policy for stroke.

“We will continue to work with the Ministry of Health and the Brazilian medical societies on the implementation of acute stroke care throughout Brazil,” said Mark A. Turco, MD, Chief Medical Officer, Vascular Therapies, Covidien. “The BSN is to be commended for making this stroke program possible. Moving forward, this educational program can be established and used as a model for other countries as well.”

The BSN was established in June 2008 to improve education, assistance and research on ischemic stroke in Brazil. Created by stroke neurologists, the BSN also includes other physicians, healthcare professionals and health authorities. Since its inception, the BSN has established an average of 12 stroke centers a year, increasing the number of Brazil’s stroke centers from 35 in 2008 to 82 today.


Covidien Launches Campaign to Increase Awareness of Pregnancy-Related Blood Clots

New “1 in 1,000” campaign helps healthcare professionals educate patients about VTE risks during pregnancy, delivery and postpartum

WASHINGTON--(BUSINESS WIRE)--Jun. 27, 2012-- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the launch of its “1 in 1,000” campaign to help educate women about the risk of pregnancy-related blood clots, one of the leading causes of maternal mortality in the developed world.1 The announcement was made at the 2012 annual meeting of the Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN).

“1 in 1,000” refers to the number of women who are likely to experience a potentially life-threatening blood clot during pregnancy, delivery or postpartum. These blood clots, called venous thromboembolism (VTE), encompass both deep vein thrombosis and pulmonary embolism.

“The increased incidence of VTE during pregnancy and the peripartum period warrants special consideration and preventive intervention,” said Randall Kuhlmann, MD, PhD, director of the Maternal Fetal Medicine Section and Maternal Fetal Care Center at Children’s Hospital of Wisconsin and Froedtert Hospital. “As an obstetrician, it is my job to protect my patients from this preventable disease by facilitating education and following the recommended guidelines for prophylaxis.”

Developed in consultation with leading women’s health experts, the “1 in 1,000” education and prevention program focuses on empowering healthcare professionals to take action against VTE. The program includes guidelines and materials on how to educate pregnant patients on the risks of VTE and highlights the importance of appropriate VTE risk assessment - as well as prevention protocols at hospitals and health systems. The Association of periOperative Registered Nurses (AORN) awarded its Seal of Recognition for “1 in 1,000” campaign program components. Additional program information and materials can be accessed at


Covidien Strives to Prevent Obstetric Fistula

Obstetric fistulas occur in women who suffer from a prolonged labor accompanied by inadequate medical attention during childbirth. This injury often results in the stillbirth of the child and incontinence of the mother. In some cultures, this causes the woman to be ostracized by her family and friends. While obstetric fistula is a disturbing injury plaguing many women throughout Africa and parts of the Middle East, it is preventable and treatable.

Covidien, in partnership with Direct Relief International, is aiding in the prevention and treatment of obstetric fistulas. Direct Relief International has launched the first interactive, global fistula map with support from the United Nations Population Fund (UNFPA) and the Fistula Foundation to provide a better understanding of the global availability of treatment for women suffering from this injury. This map is the most complete representation of locations where women are being treated around the world, as well as where the capacity for fistula treatment exists. Only one out of 50 women with an obstetric fistula receives the treatment they need.

Through Covidien’s product donations, Direct Relief International has been able to support fistula repair activities conducted at several sites on the map. With Covidien’s commitment to a philanthropic partnership with Direct Relief International, the hope is that more women will be able to receive the treatment they need and more preventative measures will be taken to end obstetric fistulas for future generations of women.


Covidien Asia’s First Dialysis Vascular Access Center in Shanghai

Covidien in China recently launched the Covidien - Changzheng Hospital Asia Training Center for Dialysis Vascular Access in Shanghai. This is the first Asia training center of its kind for Covidien.

Equipped with state-of-the-art facilities, the center will be delivering best in class education and training for healthcare professionals. The center recently concluded a course for 14 nephrologists from hospitals in the north-eastern region of China.

“The Shanghai Changzheng Hospital is the leading center in dialysis vascular access, with a strong faculty that conducts quality procedures. This collaboration between Shanghai Changzheng Hospital and Covidien aligns with our mission and vision, demonstrating our competency in providing valued educational experiences for our customers and thereby delivering quality patient outcomes,” said Peter Traianou, Senior Director, PACE, Asia.